OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Laboratory Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Molecular Pathology of Ovarian Epithelial Neoplasms	27
Molecular Detection of Oncogenic Gene Rearrangements	23
Contents	22
Current Topics in Molecular Diagnostics and Precision Medicine	21
Contributors	20
Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists	19
Digital Imaging and AI Pre-classification in Hematology	19
Breaking Through the Barrier	17
Promoting Health Equity Through Effective Laboratory Stewardship Strategies	16
Is It Possible to Test for Viral Infectiousness?	13
Inclusive Laboratory Reference Intervals and Clinical Studies to Reduce Health Disparities	12
Contributors	12
Copy Number Analysis in Cancer Diagnostic Testing	12
Molecular Oncology Diagnostics	12
Flow Cytometry-based Immune Phenotyping of T and B Lymphocytes in the Evaluation of Immunodeficiency and Immune Dysregulation	11
Point-of-Care Drug Testing	10
Automated Quality Assurance Rules for Liquid Chromatography–Mass Spectrometry Testing in a Clinical Laboratory	10
Infant Acute Leukemia	10
Gene Rearrangement Detection in Pediatric Leukemia	10
Hematopathologic Correlates of CAR T-Cell Therapy	9
Contributors	8
Contributors	8
Role of Minimal Residual Disease Testing in Acute Myeloid Leukemia	8
Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53	7
Flow Cytometry in Diagnosis, Prognostication, and Monitoring of Multiple Myeloma and Related Disorders	7

Update on Acute Leukemias of Ambiguous Lineage	7
Opportunities and Challenges with Artificial Intelligence in Genomics	7
Perspectives on Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 and Its Implications for Diagnostics, Biology, and Clinical Management	7
Contents	6
Flow Cytometry and Platelets	6
Beyond LC-MS: The Next Frontier in Clinical Mass Spectrometry	6
Contextualizing Race and Ethnicity in the Practice of Laboratory Medicine	6
Mass Cytometry, Imaging Mass Cytometry, and Multiplexed Ion Beam Imaging Use in a Clinical Setting	6
Nothing Basic About It: Guiding the Judicious Use of Diagnostic Tests	6
Cell-free Nucleic Acids in Cancer	6
Diagnostic Stewardship for Next-Generation Sequencing Assays in Clinical Microbiology	6
Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing	5
Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19	5
The Evolving Role of Molecular Diagnostics in Pathology	5
Molecular Diagnostics for Invasive Molds: From Lab to Bedside	5
Beyond LC-MS: The Next Frontier in Clinical Mass Spectrometry	5
Artificial Intelligence for Clinical Flow Cytometry	5
Copyright	5
Morphologic Characteristics of Myelodysplastic Syndromes	5
Steps Forward to a Fair and Inclusive Blood Supply	5
Leadership Approaches for Work-Life Balance, Well-Being, and Diversity, Equity, and Inclusion Support in the Laboratory	5
Contents	5
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe	5
Molecular Alterations in Pediatric Solid Tumors	5
Copyright	5
Transfusion Medicine Informatics	4
Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology	4
Rapid Antigen Assays for SARS-CoV-2	4
Artificial Intelligence in the Clinical Laboratory	4
Copyright	4
Contents	4
Update on Ovarian Sex Cord–Stromal Tumors	4
Contributors	4
Molecular Biomarkers of Response to Cancer Immunotherapy	4
Utility of Single-Gene Testing in Cancer Specimens	4
Electronic Health Record Optimization for Artificial Intelligence	4
Taking Center Stage	4
A Meta-analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Anti-spike Immunoglobulin G Antibody Durability up to 9 Months After Full Vaccination in Adults	4
Suboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant Generation	4
The Mass Spectrometry Revolution in Clinical Microbiology Part 2	4
Point of Care Molecular Testing	4
Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance)	4
Copyright	4
Molecular Methods	3
Transfusion Reactions and Adverse Events	3
Influence of Race Modifiers in Estimated Glomerular Filtration Rate Calculations on Medication Dosing, Access, and Transplant Eligibility	3
Childhood Myelodysplastic Syndrome	3
Value of Improving Result Interpretation in Direct-to-Definitive Urine Drug Panels	3
Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-2	3
Copyright	3

Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms	3
Laboratory Aspects of Minimal / Measurable Residual Disease Testing in B-Lymphoblastic Leukemia	3
Diagnostic Stewardship for Multiplex Respiratory Testing	3
Reactive Lymphadenopathies	3
Updates in Blood Banking and Transfusion Medicine	3
Molecular Pathology of Breast Tumors	3